PAUL R. FONTEYNE - Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by PAUL R. FONTEYNE since 14 Feb 2025

Holdings reported by PAUL R. FONTEYNE for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30,666 $724,637 $23.63 01 Jan 2026 Direct
Stock Option (Right to Buy) 14,684 $381,092 $66.30 01 Jan 2026 Direct Common Stock

Transactions reported by PAUL R. FONTEYNE for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.